News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
747,195 Results
Type
Article (43899)
Company Profile (347)
Press Release (702931)
Multimedia
Podcasts (99)
Webinars (20)
Section
Business (208386)
Career Advice (2084)
Deals (36021)
Drug Delivery (136)
Drug Development (82645)
Employer Resources (175)
FDA (16616)
Job Trends (15277)
News (352261)
Policy (33277)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2670)
Accelerated approval (53)
ADA (44)
Adcomms (27)
Allergies (181)
Alliances (50648)
ALS (222)
Alzheimer's disease (1832)
Antibody-drug conjugate (ADC) (498)
Approvals (17041)
Artificial intelligence (707)
ASCO (330)
Autoimmune disease (326)
Automation (60)
Bankruptcy (369)
Best Places to Work (11738)
BIOSECURE Act (21)
Biosimilars (229)
Biotechnology (230)
Bladder cancer (200)
Brain cancer (74)
Breast cancer (789)
Cancer (6171)
Cardiovascular disease (491)
Career advice (1774)
Career pathing (44)
CAR-T (352)
CDC (57)
Celiac Disease (3)
Cell therapy (955)
Cervical cancer (52)
Clinical research (72056)
Collaboration (2173)
Company closure (5)
Compensation (1466)
Complete response letters (82)
COVID-19 (2798)
CRISPR (116)
C-suite (1206)
Cystic fibrosis (157)
Data (8458)
Decentralized trials (3)
Denatured (30)
Depression (171)
Dermatology (93)
Diabetes (648)
Diagnostics (7051)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (341)
Drug pricing (206)
Drug shortages (31)
Duchenne muscular dystrophy (294)
Earnings (92822)
Editorial (68)
Employer branding (21)
Employer resources (154)
Events (123922)
Executive appointments (1125)
FDA (20502)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1814)
Gene editing (246)
Generative AI (63)
Gene therapy (758)
GLP-1 (1089)
Government (4815)
Grass and pollen (6)
Guidances (414)
Healthcare (19335)
Hematology (194)
HIV (83)
Huntington's disease (60)
IgA nephropathy (110)
Immunology and inflammation (296)
Immuno-oncology (102)
Indications (203)
Infectious disease (3154)
Inflammatory bowel disease (219)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (309)
Interviews (324)
IPO (16824)
IRA (50)
Job creations (3843)
Job search strategy (1473)
JPM (58)
Kidney cancer (20)
Labor market (107)
Layoffs (580)
Leadership (42)
Legal (8119)
Liver cancer (102)
Longevity (35)
Lung cancer (821)
Lymphoma (453)
Machine learning (63)
Management (59)
Manufacturing (1107)
MASH (203)
Medical device (14049)
Medtech (14193)
Mergers & acquisitions (20470)
Metabolic disorders (1611)
mRNA (221)
Multiple sclerosis (195)
NASH (17)
Neurodegenerative disease (444)
Neuropsychiatric disorders (107)
Neuroscience (3429)
Neurotech (1)
NextGen: Class of 2026 (6654)
Non-profit (4614)
Now hiring (79)
Obesity (743)
Opinion (305)
Ovarian cancer (233)
Pain (262)
Pancreatic cancer (335)
Parkinson's disease (386)
Partnered (33)
Patents (620)
Patient recruitment (713)
Peanut (66)
People (61199)
Pharmaceutical (69)
Pharmacy benefit managers (33)
Phase 1 (22563)
Phase 2 (31789)
Phase 3 (23504)
Pipeline (9394)
Policy (328)
Postmarket research (2584)
Preclinical (9646)
Press Release (71)
Prostate cancer (326)
Psychedelics (54)
Radiopharmaceuticals (341)
Rare diseases (1137)
Real estate (6206)
Recruiting (72)
Regulatory (25923)
Reports (57)
Research institute (2477)
Resumes & cover letters (360)
Rett syndrome (41)
RNA editing (23)
RSV (89)
Schizophrenia (182)
Series A (309)
Series B (226)
Service/supplier (11)
Sickle cell disease (123)
Special edition (25)
Spinal muscular atrophy (167)
Sponsored (48)
Startups (3780)
State (2)
Stomach cancer (18)
Supply chain (130)
Tariffs (90)
The Weekly (67)
Vaccines (1140)
Venture capital (117)
Weight loss (476)
Women's health (134)
Worklife (21)
Date
Today (167)
Last 7 days (728)
Last 30 days (3066)
Last 365 days (30844)
2026 (14776)
2025 (30681)
2024 (35737)
2023 (40511)
2022 (51748)
2021 (56237)
2020 (54651)
2019 (47140)
2018 (35536)
2017 (32661)
2016 (32225)
2015 (38211)
2014 (32010)
2013 (27045)
2012 (29411)
2011 (30024)
2010 (28150)
Location
Africa (781)
Alabama (93)
Alaska (7)
Arizona (358)
Arkansas (15)
Asia (40977)
Australia (6854)
California (13862)
Canada (3881)
China (1457)
Colorado (587)
Connecticut (607)
Delaware (425)
Europe (89605)
Florida (2050)
Georgia (443)
Hawaii (3)
Idaho (63)
Illinois (1136)
India (93)
Indiana (622)
Iowa (24)
Japan (567)
Kansas (136)
Kentucky (52)
Louisiana (56)
Maine (76)
Maryland (1646)
Massachusetts (10030)
Michigan (373)
Minnesota (745)
Mississippi (6)
Missouri (148)
Montana (36)
Nebraska (29)
Nevada (146)
New Hampshire (86)
New Jersey (3618)
New Mexico (31)
New York (3628)
North Carolina (1768)
North Dakota (10)
Northern California (6990)
Ohio (411)
Oklahoma (23)
Oregon (41)
Pennsylvania (2760)
Puerto Rico (30)
Rhode Island (51)
South America (1164)
South Carolina (86)
South Dakota (2)
Southern California (5472)
Tennessee (219)
Texas (2205)
United States (48946)
Utah (413)
Vermont (1)
Virginia (335)
Washington D.C. (82)
Washington State (1119)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
747,195 Results for "massachusetts biotechnology council inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Massachusetts’ life sciences employment dipped last year following 14 years of growth: report
Massachusetts’ life sciences jobs declined 1% in 2025, according to a new MassBioEd report. However, the report is projecting industry employment will increase 9.7% by 2030. It also noted reskilling needs for some roles, including scientists.
June 4, 2026
·
2 min read
·
Angela Gabriel
Job Trends
17 companies expected to create 400+ Massachusetts jobs add under 50
Seventeen life sciences businesses awarded Massachusetts tax incentives to add and retain 426 combined jobs hit 10% of that target as of Dec. 31. Three companies, including Novartis, had reported layoffs either last year or this year.
June 1, 2026
·
4 min read
·
Angela Gabriel
Press Releases
Council of Chief Medical Officers of Health (CCMOH) Statement to Canadians on Vaccination
April 27, 2026
·
3 min read
Press Releases
Michael J. Fox Foundation CEO Deborah W. Brooks and Patient Council Member Israel Robledo Appointed to Federal Advisory Council to Guide First-Ever U.S. Parkinson’s Strategy
April 10, 2026
·
5 min read
Job Trends
$17M in Tax Incentives Will Add 800 Life Sciences Jobs This Year in Massachusetts
Of the 25 companies receiving tax incentives in Massachusetts, 23 will add jobs outside of Boston and Cambridge. Medtronic, which is receiving the largest award, will create 220 roles in Billerica. Other recipients include AbbVie, Dyne Therapeutics and Viridian Therapeutics.
October 24, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders
January 20, 2026
·
6 min read
Press Releases
Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
February 3, 2026
·
5 min read
Job Trends
21 Companies Miss Massachusetts Hiring Targets, Affecting Hundreds of Jobs
Nearly two dozen life sciences companies that were awarded Massachusetts tax incentives to create and retain about 1,000 combined jobs hit just 13% of that target in 2024. Ten awardees had reported layoffs last year, including Charles River Laboratories and Moderna.
November 13, 2025
·
6 min read
·
Angela Gabriel
Layoffs
Replimune cuts will leave over 200 jobless in Massachusetts
Replimune is axing 144 employees at its Woburn headquarters and 80 at its Framingham manufacturing site. The cuts follow the FDA’s second rejection of the biotech’s advanced melanoma candidate.
April 21, 2026
·
1 min read
·
Angela Gabriel
Press Releases
Rentschler Biopharma Inc. named Manufacturer of the Year for Central Massachusetts
October 24, 2025
·
4 min read
1 of 74,720
Next
